A Single-Center 2-Arm Study for Lentigines on the Hands

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effectiveness and safety of two laser systems for improvement of lentigines on the hands.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Human Factors Testing for OTC Use of the Erchonia® LunulaLaser

NCT05626270

Onychomycosis

COMPLETED NA

Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference

NCT01376037

Body Contouring

COMPLETED NA

Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.

NCT00254111

Osteoarthritis

UNKNOWN NA

Study to Evaluate the Safety and Efficacy of a Low Level Light Device in Patients With Knee Osteoarthritis

NCT00375544

Osteoarthritis, Knee

COMPLETED PHASE1

Evaluation of the Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis: A Prospective Double Blind, Randomized, Sham-Controlled Clinical Study

NCT04276038

Knee Osteoarthritis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the effectiveness and safety in a clinic setting of two laser systems for the treatment of lentigines (liver spots, age spots, or dark sun spots) on the hands.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lentigines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enlighten Laser

12 subjects will receive treatment the Enlighten laser.

Group Type EXPERIMENTAL

Enlighten Laser

Intervention Type DEVICE

Excel V Laser

12 subjects will receive treatment with the Excel V laser.

Group Type ACTIVE_COMPARATOR

Excel V Laser

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enlighten Laser

Intervention Type DEVICE

Excel V Laser

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female or Male, 30-90 years of age (inclusive).
2. Fitzpatrick Skin Type I - III.
3. Desires non-invasive and non-ablative treatment of lentigines on the hand(s).
4. Have 4 or more lentigines on the hand(s).
5. Subject must be able to read, understand and sign the Informed Consent Form.
6. Must be willing and able to adhere to the treatment and follow-up schedule and post-treatment care instructions.
7. Willing to have very limited sun exposure and use an approved sunscreen of SPF 50 or higher on the treatment area every day for the duration of the study, including the follow-up period.
8. Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, educational or marketing purposes.
9. Agree to not undergo any other procedure(s) for treatment of lentigines during the study, including but not limited to chemical peel, laser and light based device treatment, and home-use device treatment.
10. Agree to not undergo any injection of botulinum toxin, collagen, hyaluronic acid filler or other dermal filler to the treatment area during the study.

Exclusion Criteria

1. Participation in a clinical trial of another device or drug in the target area within 6 months prior to enrollment or during the study.
2. Any type of prior cosmetic treatment to the target area within 6 months of study participation, such as laser or light-based procedures or surgery.
3. Systemic use of retinoid, such as isotretinoin, within 6 months of study participation.
4. Use of topical medications on the hands, such as antibiotics, benzoyl peroxide, retinoids (isotretinoin), corticosteroids, hydroquinone, or products containing dihydroxyacetone or alpha-hydroxy with concentration \> 8%, within 1 month of participation.
5. History of malignant tumors in the target area.
6. Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles.
7. Pregnant.
8. Having an infection, dermatitis, or a rash in the treatment area.
9. History of keloid scarring, hypertrophic scarring or of abnormal wound healing.
10. Any use of medication that is known to increase sensitivity to light according to investigator's discretion.
11. History of radiation to the treatment area or undergoing systemic chemotherapy for the treatment of cancer.
12. History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation.
13. Anytime in life, having have used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus.
14. Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study.
15. In the opinion of the investigator, any physical or mental condition which might make it unsafe for the subject to participate in this study or which requires systematic therapy that could interfere with this research study.

Minimum Eligible Age

30 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes